POPULAR SECTIONS

TREATMENT REGIMENS DRUG INFO MEDICAL CALCULATORS PUBLISHERS ALLIANCE VIDEOS CME

CTA Community Poll

How Does Your Work Life Balance Compare to Your Peers?


We recently asked our readers some questions about their work/life balance as it relates to their oncology-related careers.

Slideshows

ABRAXANE® (paclitaxel protein-bound particles) (albumin-bound) for Pancreatic Cancer

This slideshow reviews drug information for ABRAXANE® (paclitaxel protein-bound particles) (albumin-bound), indicated for adenocarcinoma of the pancreas.

ABRAXANE® (paclitaxel protein-bound particles) (albumin-bound) for NSCLC

This slideshow reviews ABRAXANE® (paclitaxel protein-bound particles) (albumin-bound) for patients with non-small cell lung cancer.

ADCETRIS™ (brentuximab vedotin)

This slideshow reviews drug information for ADCETRIS™ (brentuximab vedotin).

AFINITOR® (everolimus) for Neuroendocrine Tumors of the Pancreas

Review drug information for AFINITOR® (everolimus) for treatment of neuroendocrine tumors of the pancreas.

ALIMTA® (pemetrexed)

Review drug information for ALIMTA® (pemetrexed).

AVASTIN® (bevacizumab)

Review drug information for AVASTIN® (bevacizumab).

BOSULIF® (bosutinib)

This slideshow reviews drug information for BOSULIF® (bosutinib).

COMETRIQ™ (Cabozantinib)

This slideshow reviews drug information for COMETRIQ™ (cabozantinib).

GAZYVA® (obinutuzumab) For Chronic Lymphocytic Leukemia

This slideshow reviews drug information for GAZYVA® (obinutuzumab)

GRANIX® (tbo-filgrastim)

This slideshow reviews drug information for GRANIX® (tbo-filgrastim) for management of severe neutropenia.

ICLUSIG™ (ponatinib)

This slideshow reviews drug information for ICLUSIG™ (ponatinib).

IMBRUVICA® (ibrutinib)

This slideshow reviews drug information for IMBRUVICA® (ibrutinib), indicated for mantle cell lymphoma.

INLYTA® (axitinib)

Review drug information for INLYTA®, indicated for advanced renal cell carcinoma.

JAKAFI® (ruxolitinib)

Review drug information slides for JAKAFI® (ruxolitinib), indicated for treatment of myelofibrosis.

KADCYLA™ (ado-trastuzumab emtansine)

This slideshow reviews drug information for KADCYLA™ (ado-trastuzumab emtansine).

MARQIBO® (vinCRIStine sulfate LIPOSOME injection)

This slideshow reviews drug information for MARQIBO® (vinCRIStine sulfate LIPOSOME injection)

MEKINIST™ (trametinib)

This slideshow reviews drug information for MEKINIST™ (trametinib).

PERJETA® (pertuzumab)

This slideshow reviews drug information for PERJETA® (pertuzumab), indicated for neoadjuvant treatment of breast cancer.

POMALYST® (pomalidomide)

This slideshow reviews drug information for POMALYST® (pomalidomide).

REVLIMID® (lenalidomide)

Review drug information for REVLIMID® (lenalidomide) for treatment of patients with mantle cell lymphoma.

ZYDELIG® (idelalisib) for Relapsed Follicular B-cell Non-Hodgkin Lymphoma (FL)

ZYDELIG® (idelalisib) for Relapsed Follicular B-cell Non-Hodgkin Lymphoma (FL)

This slideshow reviews drug information for ZYDELIG® (idelalisib), indicated for relapsed follicular non-Hodgkin lymphoma (FL).

Table of Contents

Slide 3: Indication, Dosage, ...

ZYDELIG® (idelalisib) for Relapsed Chronic Lymphocytic Leukemia

ZYDELIG® (idelalisib) for Relapsed Chronic Lymphocytic Leukemia

This slideshow reviews drug information for ZYDELIG® (idelalisib), indicated for relapsed chronic lymphoma.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide ...

ZYKADIA™ (ceritinib)

ZYKADIA™ (ceritinib)

This slideshow reviews drug information for ZYKADIA™ (ceritinib), indicated for anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC).

Table ...

PURIXAN® (mercaptopurine [6-MP] oral suspension)

PURIXAN® (mercaptopurine [6-MP] oral suspension)

This slideshow reviews drug information for PURIXAN® (mercaptopurine [6-MP] oral suspension), indicated for acute lymphoblastic leukemia.

Table of Contents

Slide 3: Indication, ...

SYLATRON® (peginterferon alfa-2b)

SYLATRON® (peginterferon alfa-2b)

Review slide-by-slide drug information for SYLATRON® (peginterferon alfa-2b) for treatment of melanoma.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 8: ...

XELODA®

XELODA®

This slideshow reviews drug information for XELODA® (capecitabine) for treatment of metastatic breast cancer.

Table of Contents

Slide 3: Indication, Dosage, and ...

AFINITOR® (everolimus) for Neuroendocrine Tumors of the Pancreas

AFINITOR® (everolimus) for Neuroendocrine Tumors of the Pancreas

This slideshow reviews drug information for AFINITOR® (everolimus) for neuroendocrine tumors of the pancreas.


Table of Contents

Slide 3: Indication, Dosage, and ...

VOTRIENT® (pazopanib) for Renal Cell Carcinoma

VOTRIENT® (pazopanib) for Renal Cell Carcinoma

This slideshow reviews drug information for VOTRIENT® (pazopanib) for renal cell carcinoma.


Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 6: ...

GRANIX® (tbo-filgrastim) for Management of Severe Neutropenia

GRANIX® (tbo-filgrastim) for Management of Severe Neutropenia

This slideshow reviews drug information for GRANIX® (tbo-filgrastim) for management of severe neutropenia.


Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide ...

Notable Electronic Health Record Milestones

Notable Electronic Health Record Milestones

Since 2008, electronic health record adoption has increased 41% -- an rise attributable to a mandate from the U.S. government ...

Sign Up for Free e-newsletters

CTA Community Poll

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs